AC Immune (ACIU) Other financing activities (2015 - 2025)

AC Immune (ACIU) has 11 years of Other financing activities data on file, last reported at $205018.0 in Q3 2025.

• On a quarterly basis, Other financing activities rose 105.65% year-over-year to $205018.0 in Q3 2025; TTM through Sep 2025 was -$3.7 million, a 215.17% decrease from a year earlier, with the FY2016 full-year figure at $18.3 million, down 36.79% from the prior year.
• Other financing activities for Q3 2025 stood at $205018.0, down from $478267.7 in the prior quarter.
• Over the last five years, Other financing activities for ACIU reached as high as $8.5 million in Q1 2021 and fell as low as -$8.1 million in Q2 2022.
• Historically, Other financing activities has averaged $763391.5 across 5 years, with a median of -$20836.3 in 2021.
• Across the five-year window, Other financing activities soared 3291.21% in 2021 and sank 38892.74% in 2022, its largest moves.
• Year by year, Other financing activities stood at $5.1 million in 2021, then soared by 53.69% to $7.8 million in 2022, then tumbled by 101.95% to -$152443.9 in 2023, then sank by 2281.19% to -$3.6 million in 2024, then soared by 105.65% to $205018.0 in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were $205018.0 in Q3 2025, $478267.7 in Q1 2025, and -$3.6 million in Q3 2024.